Compare BLZE & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLZE | SGHT |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.2M | 489.7M |
| IPO Year | 2021 | 2021 |
| Metric | BLZE | SGHT |
|---|---|---|
| Price | $6.92 | $10.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $21.50 | $12.25 |
| AVG Volume (30 Days) | ★ 2.7M | 364.6K |
| Earning Date | 11-02-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.56 | 28.16 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $145,835,000.00 | $77,363,000.00 |
| Revenue This Year | $22.07 | $19.69 |
| Revenue Next Year | $25.20 | $12.19 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 14.27 | N/A |
| 52 Week Low | $3.26 | $3.38 |
| 52 Week High | $23.99 | $11.60 |
| Indicator | BLZE | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 33.59 | 64.23 |
| Support Level | $6.82 | $7.88 |
| Resistance Level | $9.17 | N/A |
| Average True Range (ATR) | 0.76 | 0.63 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 8.02 | 62.26 |
Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.